Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]

View source ↗

Summary

Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Fibrosarcoma
• Intracranial Hemangiopericytoma
• Leiomyosarcoma
• Malignant Meningioma
• Rhabdomyosarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Chondrosarcoma, Adult Fibrosarcoma | Phase 2 | Status: TERMINATED